U.S. RESEARCH ROUNDUP-Braze, Gulfport Energy, Maplebear

April 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Braze, Gulfport Energy and Maplebear, on Monday.

HIGHLIGHTS

* Braze Inc : BTIG cuts target price to $68 from $75

* Gulfport Energy Corp : Truist Securities raises target price to $203

from $184

* Maplebear Inc : Baird raises target price to $44 from $31

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Akebia Therapeutics Inc : BTIG raises target price to $5 from $4

* Braze Inc : BTIG cuts target price to $68 from $75

* Bristol-Myers Squibb Co : Jefferies raises target price to $58 from $56

* Cogent Biosciences Inc : Jefferies raises target price to $20 from $18

* EPR Properties : JP Morgan cuts target price to $49 from $51

* Exxon Mobil : TD Cowen raises target price to $120 from $115

* Forge Global Holdings Inc : Piper Sandler cuts target price to $2 from $2.50

* Gulfport Energy Corp : Truist Securities raises target price to $203 from $184

* Home Depot Inc : Telsey Advisory Group raises target price to $360 from $335

* Kodiak Sciences Inc : Jefferies raises target price to $7 from $3.5

* Maplebear Inc : Baird raises target price to $44 from $31

* Materion Corp : KeyBanc cuts target price to $156 from $157

* Omega Therapeutics Inc : Chardan Capital Markets cuts PT to $7 from $12

* Paysign Inc : D.A. Davidson raises target price to $4.5 from $4

* Red Rock Resorts Inc : JP Morgan raises target price to $69 from $63

* Semtech Corp : Benchmark raises target price to $40 from $30

* TD Synnex Corp : JP Morgan raises target price to $126 from $113

* Torrid Holdings Inc : Jefferies raises target price to $4.8 from $4

* Walgreens : Jefferies cuts target price to $19 from $22.5

* Xilio Therapeutics Inc : Raymond James cuts target price to $6 from $13

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))